Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited    600332   CNE000001733

GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLD

(600332)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Sector news Pharmaceuticals - NEC
11:36aCANOPY GROWTH : Pot producer Canopy Growth reels under slow retail store opening..
RE
11:10aCisco's Disappointing Outlook Weighs on Stocks
DJ
10:36aDAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
10:36aWalt Disney soars while Cisco disappoints
09:35aALLERGAN : Form 8.3 -
DJ
09:32aABBVIE : Form 8.3 - -2-
DJ
09:32aABBVIE : Form 8.3 -
DJ
08:48aBAYER : to Work With Dewpoint Therapeutics to Develop New Therapies
DJ
07:42aALLERGAN : Exicure and Allergan Agree to Develop Hair-Loss Treatment
DJ
07:41aMerck, AstraZeneca Get FDA Priority Review for Selumetinib in NF1
DJ
03:43aMerck KGaA raises 2019 guidance after Versum takeover
RE
03:20aAs swine fever fries China vaccine sales, Boehringer rewrites prescription fo..
RE
02:48aAbbott's White To Step Down as Chief Executive -- WSJ
DJ
02:48aUnilever Makes Second Change at the Top -- WSJ
DJ
01:37aMERCK : 3Q Net Profit, Revenue Rose
DJ
11/13Longtime Abbott Labs CEO Miles White to Step Down in March -- 2nd Update
DJ
11/13Longtime Abbott Labs CEO Miles White to Step Down in March -- Update
DJ
11/13ALLERGAN : Form 8.3 - Allergan Plc -2-
DJ
11/13ALLERGAN : Form 8.3 - Allergan Plc
DJ
11/13MEDIATION BETWEEN BAYER, PLAINTIFFS : U.S. mediator
RE
11/13Unilever Names Former Maersk CEO as Chairman
DJ
11/13CREDIT MARKETS : AbbVie's $30 Billion Sale of Debt Draws Strong Demand -- WSJ
DJ
11/12ABBVIE : Sells $30 Billion of Bonds -- 2nd Update
DJ
11/12AbbVie Prepares Large Bond Sale -- Update
DJ
11/12ABBVIE : Prepares Large Bond Sale to Fund Allergan Purchase
DJ
11/12MYLAN N : and Pfizer Say Combined -Upjohn to Be Called Viatris
DJ
11/12ALLERGAN : Form 8.3 - Allergan Plc
DJ
11/12Wall Street in full speed
11/12MERCK : Licenses CRISPR Gene-Editing Technology to Evotec
DJ
11/12ELI LILLY AND : Says Taltz Met Endpoints in Axial Spondyloarthritis Study
DJ
11/12GOSSAMER BIO : in Agreement with Merck for Solid Tumor Studies
DJ
11/12PFIZER : Xeljanz Study in Juvenile Idiopathic Arthritis Met Primary Endpoint
DJ
11/11MERCK AND : Gets Conditional European Commission Approval for Ebola Vaccine
DJ
11/11GLOBAL MARKETS LIVE : Tencent, Alibaba, Boeing, Apple…
11/11ALLERGAN : Form 8.3 -
DJ
11/11J&J'S JANSSEN : Tremfya Meets Main Endpoints in Psoriatic Arthritis Studies
DJ
11/11ANDREW WITTY : UnitedHealth Group Names Andrew Witty as President
DJ
11/11ALLERGAN : Gets FDA Fast-Track, Qualified Infectious Disease Status for ATM-AVI
DJ
11/11BRISTOL MYERS SQUIBB : Myers Gets FDA Priority Review, Breakthrough Designation ..
DJ
11/11ASPEN PHARMACARE : Novartis buys Aspen's Japanese generic unit for up to 400 mil..
RE
11/11NOVARTIS : Sandoz generics unit buying Aspen's Japanese operations
RE
11/08FibroGen, AstraZeneca Up After Roxadustat Data
DJ
11/08ACCELERON PHARMA : Shares Gain Ground After FDA Approves Reblozyl
DJ
11/08CELGENE : FDA Approves Celgene's and Acceleron's Reblozyl to Treat Rare Blood Di..
DJ
11/08ALLERGAN : Form 8.3 - Allergan Plc
DJ
11/08JOHNSON & JOHNSON : J&J's Janssen Gets Health Canada OK for Expanded Imbruvica U..
DJ
11/08PFIZER, MERCK KGAA : Bavencio Misses Main Endpoint in Gastric Cancer Study
DJ
11/08JOHNSON & JOHNSON : J&J's Janssen Seeks FDA OK for Expanded Imbruvica Use
DJ
11/08AstraZeneca Finds Increased Hemoglobinin in Roxadustat Phase 3 Trial
DJ
11/07TEVA PHARMACEUTICAL INDUSTRIES : High Debt, Potential Litigation Costs Face New ..
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on GUANGZHOU BAIYUNSHAN PHARM